IPO

Invicta Diagnostic Limited IPO

NSE SME

Offer Date: Dec 1, 2025 - Dec 3, 2025

₹ 272000 /3200 Shares
*Min Investment

01 Dec, 2025

Open Date

03 Dec, 2025

Close Date

04 Dec, 2025

Allotment Date

08 Dec, 2025

Listing Date
Invicta Diagnostic IPO Issue Details
  • Issue Price ₹80-85 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 33,08,800 shares(aggregating up to ₹28.12 crore)
  • Fresh Share 33,08,800 shares(aggregating up to ₹28.12 crore)
  • Listing at NSE SME
  • Lead Manager Socradamus Capital Pvt Ltd
  • Registrar Bigshare Services Pvt Ltd
Market Lot Size

Investors can bid for a minimum of 3200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Individual (min)23200₹2,72,000
Individual(max)23200₹2,72,000
SHNI(min) 34800₹4,08,000
SHNI(max) 711,200₹9,52,000
BHNI(min) 812,800₹10,88,000
Invicta Diagnostic IPO Reservation

Invicta Diagnostic IPO offers total 0 shares. Out of which NA (NA%) allocated to QIB, 0 (NA%) allocated to NII,0 (NA%) allocated to RII, NA (NA%) allocated to employees and NA (NA%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares OfferedNA (NA%)
Market Maker Shares OfferedNA (NA%)
QIB Shares OfferedNA (NA%)
NII (HNI) Shares Offered0 (NA%)
Individual Shares Offered0 (NA%)
Total Shares Offered0 (100%)
Invicta Diagnostic IPO Documents
Invicta Diagnostic IPO Details


Invicta Diagnostic Limited IPO is an SME IPO, priced at ₹80-85 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 33,08,800 equity shares, aggregating up to ₹28.12 crores..

The IPO bidding window is open from Dec 1, 2025 to Dec 3, 2025. The allotment is expected to be finalized on Dec 4, 2025, and the tentative listing date is Dec 8, 2025.

The minimum lot size for Individual investors is 3200 shares, with a minimum investment of ₹2,72,000.

Socradamus Capital Pvt Ltd is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and

Read More
Invicta Diagnostic Valuations
EPS Pre IPO ₹/-
EPS Post IPO ₹/-
Market Cap. Cr.
Invicta Diagnostic Company Financials
In Crs.
In Cr.
31-Mar-2531-Mar-2431-Mar-23
Assets21.2215.89N/A
Revenue30.1815.90N/A
Profit After Tax4.933.81N/A
Net Worth13.608.67N/A
Reserves & Surplus5.188.54N/A
Total Borrowing3.543.81N/A
About Invicta Diagnostic Company

Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.

Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West
Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services
Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa.
It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations.

Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels.

Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.

Read More
Invicta Diagnostic - Promoter(s)

Dr. Ketan Jayantilal Jain

Dr. Sanket Vinod Jain

Rohit Prakash Srivastava

Badal Kailash Naredi

Jayesh Prakash Jain

Pre Issue Share Holding : %

Post Issue Share Holding : %

Invicta Diagnostic IPO - Issue Objectives
1

Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra

2

General Corporate purposes

Contact Details

Invicta Diagnostic

1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai, Maharashtra, 400013

022-4971-0036

investors@pcdiagnostics.in

https://www.pcdiagnostics.in/

Registrar Contact Details